òòò½Íø

Search

Showing 6,961-6,980 of 18,045 items.

The Top 1 Percent in International and Historical Perspective

[Symposium: The Top 1 Percent]

By Facundo Alvaredo, Anthony B. Atkinson, Thomas Piketty, and Emmanuel Saez

Journal of Economic Perspectives, Summer 2013

The top 1 percent income share has more than doubled in the United States over the last 30 years, drawing much public attention in recent years. While other English-speaking countries have also experienced sharp increases in the top 1 percent income sha...

Salience and Asset Prices

By Pedro Bordalo, Nicola Gennaioli, and Andrei Shleifer

òòò½Íø Review, May 2013

We present a simple model of asset pricing in which payoff salience drives investors' demand for risky assets. The key implication is that extreme payoffs receive disproportionate weight in the market valuation of assets. The model accounts for several pu...

Pricing in the Market for Anticancer Drugs

By David H. Howard, Peter B. Bach, Ernst R. Berndt, and Rena M. Conti

Journal of Economic Perspectives, Winter 2015

In 2011, Bristol-Myers Squibb set the price of its newly approved melanoma drug ipilimumab— brand name Yervoy—at $120,000 for a course of therapy. The drug was associated with an incremental increase in life expectancy of four months. Drugs ...